WILLIAM RETTERBUSH: Open Payments
NPI 1053934844 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,594 in 110 payments from 18 companies in 2025. Trend: 2023 $1,806 · 2024 $2,615 · 2025 $2,594
Food & beverage: $2,490Education: $105
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $418 |
| UCB, Inc. | 9 | $378 |
| Regeneron Healthcare Solutions, Inc. | 9 | $258 |
| Novartis Pharmaceuticals Corporation | 11 | $254 |
| Galderma Laboratories, L.P. | 12 | $197 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $191 |
| Janssen Biotech, Inc. | 4 | $168 |
| PFIZER INC. | 6 | $146 |
| Botanix SB Inc | 6 | $114 |
| LEO Pharma Inc. | 4 | $95 |
Products named: Bimzelx, DUPIXENT, SKYRIZI, TREMFYA, RINVOQ, NEMLUVIO, CIBINQO, Odomzo.
Industry payments across GA — which companies pay providers there.
